Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stratified Screening of Blood Biomarkers for Alzheimer's Disease: a Prospective, Real World, Community-based Study

NCT07570719 is registered in ClinicalTrials.gov with Kuang XiaoJun as lead sponsor.

NCT NCT07570719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stratified Screening of Blood Biomarkers for Alzheimer's Disease: a Prospective, Real World, Community-based Study
Lead sponsor
Kuang XiaoJun
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2026
Completion date
March 31, 2028
Enrollment
3,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease(ad), cognitive impairment, mild cognitive impairment (mci)